| Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga, L Pache, ... Nature 586 (7827), 113-119, 2020 | 793 | 2020 |
| MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells X Yin, L Riva, Y Pu, L Martin-Sancho, J Kanamune, Y Yamamoto, K Sakai, ... Cell reports 34 (2), 2021 | 403 | 2021 |
| Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 S Yuan, X Yin, X Meng, JFW Chan, ZW Ye, L Riva, L Pache, CCY Chan, ... Nature 593 (7859), 418-423, 2021 | 201 | 2021 |
| Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes/macrophages [S] L L'homme, N Esser, L Riva, A Scheen, N Paquot, J Piette, ... Journal of lipid research 54 (11), 2998-3008, 2013 | 195 | 2013 |
| Hepatitis C virus life cycle and lipid metabolism CI Popescu, L Riva, O Vlaicu, R Farhat, Y Rouillé, J Dubuisson Biology 3 (4), 892-921, 2014 | 154 | 2014 |
| Drug repurposing screens identify chemical entities for the development of COVID-19 interventions MA Bakowski, N Beutler, KC Wolff, MG Kirkpatrick, E Chen, TTH Nguyen, ... Nature communications 12 (1), 3309, 2021 | 112 | 2021 |
| Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication G Garcia, A Sharma, A Ramaiah, C Sen, A Purkayastha, DB Kohn, ... Cell reports 35 (1), 2021 | 101 | 2021 |
| A large-scale drug repositioning survey for SARS-CoV-2 antivirals L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga, ... BioRxiv, 2020.04. 16.044016, 2020 | 94 | 2020 |
| A large-scale drug repositioning survey for SARS-CoV-2 antivirals L Riva, S Yuan, X Yin, L Martin-Sancho, N Matsunaga, ... BioRxiv, 2020.04. 16.044016, 2020 | 93 | 2020 |
| Hepatitis C virus envelope glycoprotein E1 forms trimers at the surface of the virion P Falson, B Bartosch, K Alsaleh, BA Tews, A Loquet, Y Ciczora, L Riva, ... Journal of virology 89 (20), 10333-10346, 2015 | 79 | 2015 |
| Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA SM Yoh, JI Mamede, D Lau, N Ahn, MT Sánchez-Aparicio, J Temple, ... Molecular cell 82 (15), 2871-2884. e6, 2022 | 37 | 2022 |
| Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagy L Martin-Sancho, S Tripathi, A Rodriguez-Frandsen, L Pache, ... Nature Microbiology 6 (10), 1319-1333, 2021 | 34 | 2021 |
| Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets K Cheng, L Martin‐Sancho, LR Pal, Y Pu, L Riva, X Yin, S Sinha, NU Nair, ... Molecular systems biology 17 (11), e10260, 2021 | 32 | 2021 |
| Varicella-zoster virus induces the formation of dynamic nuclear capsid aggregates M Lebrun, N Thelen, M Thiry, L Riva, I Ote, C Condé, P Vandevenne, ... Virology 454, 311-327, 2014 | 25 | 2014 |
| ORF9p phosphorylation by ORF47p is crucial for the formation and egress of varicella-zoster virus viral particles L Riva, M Thiry, S Bontems, A Joris, J Piette, M Lebrun, C Sadzot-Delvaux Journal of virology 87 (5), 2868-2881, 2013 | 25 | 2013 |
| Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters S Yuan, X Yin, XZ Meng, J Chan, ZW Ye, L Riva, L Pache, CCY Chan, ... Research square, 2020 | 21 | 2020 |
| The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking De Novo Formation of the Membranous Replication Compartment L Riva, S Goellner, SB Biering, CT Huang, AN Rubanov, U Haselmann, ... Journal of Virology 95 (22), 10.1128/jvi. 00996-21, 2021 | 18 | 2021 |
| Varicella-zoster virus ORF9p binding to cellular adaptor protein complex 1 is important for viral infectivity M Lebrun, J Lambert, L Riva, N Thelen, X Rambout, C Blondeau, M Thiry, ... Journal of Virology 92 (15), 10.1128/jvi. 00295-18, 2018 | 16 | 2018 |
| Identification of piperazinylbenzenesulfonamides as new inhibitors of Claudin-1 trafficking and hepatitis C virus entry L Riva, OR Song, J Prentoe, F Helle, L L'homme, CH Gattolliat, ... Journal of Virology 92 (10), 10.1128/jvi. 01982-17, 2018 | 16 | 2018 |
| Similarities and differences between HCV Pseudoparticle (HCVpp) and cell culture HCV (HCVcc) in the study of HCV L Riva, J Dubuisson Hepatitis C Virus Protocols, 33-45, 2019 | 12 | 2019 |
L'homme LaurentInserm UMR1011, Lille (France)Zweryfikowany adres z inserm.fr